The observed decrease in gluconeogenic enzyme mRNA, like G6Pase and PEPCK (Figure 4D), showcases RG saponin’s ability to influence insulin pathways and manage metabolic disorders by fine-tuning critical metabolic processes. The gene discussed is PCK2; the disease is metabolic disease.